The 2022 Virtual Global Walk


To celebrate hae day :-) over 5,000 people around the world contributed their steps to the 2022 Virtual Global Walk. Thank you to the 911 Canadians who added their steps to help make this awareness campaign

The 2022 Virtual Global Walk2022-06-22T13:19:40-06:00

Health Canada Approves ORLADEYO


We are thrilled to share BioCryst Pharmaceutical's big announcement: Health Canada has approved their oral, once-daily ORLADEYO® (berotralstat) for the routine prevention of HAE attacks in patients 12 years and older. Please CLICK HERE for

Health Canada Approves ORLADEYO2022-06-06T12:50:06-06:00
Go to Top